Cargando…

Orphan Drug Pricing and Costs: A Case Study of Kalydeco and Orkambi

BACKGROUND: A common narrative is that high prices are necessary for “orphan drugs” because of the fewer patients. In the context of state health insurance systems, the high prices create significant challenges because of limited budgets. RESULTS: This study carefully examines both costs and revenue...

Descripción completa

Detalles Bibliográficos
Autor principal: Hollis, Aidan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Longwoods Publishing 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7008693/
https://www.ncbi.nlm.nih.gov/pubmed/31629457
http://dx.doi.org/10.12927/hcpol.2019.25937

Ejemplares similares